Page last updated: 2024-10-24

celecoxib and Tuberculosis, Pulmonary

celecoxib has been researched along with Tuberculosis, Pulmonary in 2 studies

Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mortensen, R1
Clemmensen, HS1
Woodworth, JS1
Therkelsen, ML1
Mustafa, T1
Tonby, K1
Jenum, S1
Agger, EM1
Dyrhol-Riise, AM1
Andersen, P1
Lee, JH1
Park, HK1
Heo, J1
Kim, TO1
Kim, GH1
Kang, DH1
Song, GA1
Cho, M1
Kim, DS1
Kim, HW1
Lee, CH1

Other Studies

2 other studies available for celecoxib and Tuberculosis, Pulmonary

ArticleYear
Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate
    Communications biology, 2019, Volume: 2

    Topics: Adoptive Transfer; Aerosols; Animals; Bacterial Load; Celecoxib; Cell Differentiation; Cyclooxygenas

2019
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs.
    Journal of Korean medical science, 2008, Volume: 23, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Arthritis; Celecoxib; Drug Er

2008